Study to Evaluate Efficacy and Safety of PENNEL Capsule in the Patients With Chronic Liver Disease
Status:
Completed
Trial end date:
1998-05-01
Target enrollment:
Participant gender:
Summary
The drug in this study is combined product of biphenyl dimethyl dicarboxylate (DDB) and
garlic oil. This components showed synergistic enhancing effects in previous tests. In phase
2 test, 6 cap three times a day dosage (2cap T.I.D) is better than other dosage. Based on
above, this study is phase 3 test to prove efficacy and safety of PENNEL.